- Nucleic Acid Testing (NAT) for Human Immunodeficiency Virus Type 1 (HIV-1) and Hepatitis C Virus (HCV): Testing, Product Disposition, and Donor Deferral and Reentry; Guidance for Industry (PDF - 277KB) Updated: 12/28/2017
viernes, 29 de diciembre de 2017
Nucleic Acid Testing (NAT) for Human Immunodeficiency Virus Type 1 (HIV-1) and Hepatitis C Virus (HCV): Testing Product Disposition, and Donor Deferral and Reentry; Guidance for Industry
Nucleic Acid Testing (NAT) for Human Immunodeficiency Virus Type 1 (HIV-1) and Hepatitis C Virus (HCV): Testing Product Disposition, and Donor Deferral and Reentry; Guidance for Industry
![](https://blogger.googleusercontent.com/img/proxy/AVvXsEh74P7qmkHBRpE8WNBcdtmoF4O4P2HZ9uo-EHu3Z14pgHl0F-3baqeESxDF5edkC7CTsV3P64y2x8_VHLpk9mFz586mK5h-JBrTcc3WcW6mBYBuMkqvjF5bHehyphenhyphenmGcZ7tN1ZDDHX4xGRe9uFar0R_9NIQ7ZNZBSue6ew-JssvTJxaTx_A-An0poefzEGHsaQZ5KRvIdlNhYIfZyz1rkaPbhfJN-BYYYSwsEkTtxaMckaStezXt3upwHw7gFDHyabUCneQDND9i5iLzjIc1VSFxAZK2Hphpb1g=s0-d-e1-ft)
![](https://blogger.googleusercontent.com/img/proxy/AVvXsEh0ksucp-9dNKwQLk9wTY6GwbDNogwM-HxnVwuhD_exhf1J29rGYjfc6TGpSUQdwWMxHfyjhUjbRzs6nNiG99e8SGK8XRIOGgmxToyEgd_5Yq2PjyoWcHGsWjJAflutm362zxJmZoXAU37nmKEz_QzbEpnrQtDRbQAcwsGwarCpWbAPxTHjGDIPJSDV1hD0foDrh822Tz9BqZAIKdZc7EbqP64fyRtLo_jNsbhH58nCgo-N9ngsWmCrjW0PHnR8416MKEFsxcElROasDxLJZ5tsip_h8tLpDEn_HJ3UqQfHpBMCUIeI=s0-d-e1-ft)
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario